CD44 and ovarian carcinoma: The association of ALDH1 (br) expression with CD44 in ovarian cancer cells was shown to increase resistance to treatment [105], whereas the results obtained by Chang et al. indicate that ALDH1 was a positive prognostic factor in ovarian cancer therapy [106].